{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/tonymontalto/Library/Python/3.9/lib/python/site-packages/urllib3/__init__.py:35: NotOpenSSLWarning: urllib3 v2 only supports OpenSSL 1.1.1+, currently the 'ssl' module is compiled with 'LibreSSL 2.8.3'. See: https://github.com/urllib3/urllib3/issues/3020\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import pickle\n",
    "import os\n",
    "import gdown\n",
    "from sklearn.linear_model import Ridge\n",
    "from sklearn.ensemble import RandomForestRegressor\n",
    "from sklearn.model_selection import GridSearchCV, RandomizedSearchCV\n",
    "from sklearn.metrics import mean_squared_error\n",
    "import xgboost as xgb\n",
    "from tensorflow.keras.models import Sequential, load_model\n",
    "from tensorflow.keras.layers import Conv1D, MaxPooling1D, Flatten, Dense\n",
    "from tensorflow.keras.callbacks import ModelCheckpoint\n",
    "import joblib\n",
    "import time"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Import Models and Datasets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Should take about 3 minutes if files not already present\n",
    "# Import pretrained models\n",
    "path = \"./\"\n",
    "m = \"model_\"\n",
    "models = [\"lr.sav\", \"rf.sav\", \"xgb.sav\", \"ffnn.keras\", \"cnn.keras\"]\n",
    "model_urls = [\n",
    "    \"https://drive.google.com/file/d/1cQfOEH3b6-dxVMkEL2aM8N5p5Zt9jNJw/view?usp=drive_link\",\n",
    "    \"https://drive.google.com/file/d/1OqREa20mOlTnZVdsZ-_lKBfkwIl4fJYG/view?usp=drive_link\",\n",
    "    \"https://drive.google.com/file/d/1Q4mzsXIL4bX8sXpG6mMpvjCmvXgT9eh2/view?usp=drive_link\",\n",
    "    \"https://drive.google.com/file/d/1AV2IFpEU7EGn4ZOJWgmKdoq-ghxUaEjD/view?usp=drive_link\",\n",
    "    \"https://drive.google.com/file/d/1Try-1FfpfbXPJGq94wm9ZuawaZHZIzuU/view?usp=drive_link\",\n",
    "]\n",
    "\n",
    "# Import Incompleted studies to add to Dashboard DataFrame\n",
    "x = \"X_\"\n",
    "y = \"y_\"\n",
    "incompleted = \"incompleted.pkl\"\n",
    "groups = [\"X_incompleted.pkl\", \"X_incompleted_pca.pkl\", \"y_incompleted.pkl\"]\n",
    "group_urls = [\n",
    "    \"https://drive.google.com/file/d/1-EmGbMENBqMZwH9xxyNujwKnsDiVL3mD/view?usp=drive_link\",\n",
    "    \"https://drive.google.com/file/d/1RQgpE9CgNhpJAKqIX5z_wi3yItRu7pCo/view?usp=drive_link\",\n",
    "    \"https://drive.google.com/file/d/1Z3KF8b1ntL5quFkv71aGD0vF6DNM8S4Q/view?usp=drive_link\",\n",
    "]\n",
    "\n",
    "for i, model in enumerate(models):\n",
    "    if os.path.isfile(path + m + model):\n",
    "        pass\n",
    "    else:\n",
    "        output = m + model\n",
    "\n",
    "        gdown.download(model_urls[i], output, fuzzy=True)\n",
    "\n",
    "\n",
    "for i, group in enumerate(groups):\n",
    "    if os.path.isfile(path + group):\n",
    "        pass\n",
    "    else:\n",
    "        output = group\n",
    "\n",
    "        gdown.download(group_urls[i], output, fuzzy=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nctId</th>\n",
       "      <th>status</th>\n",
       "      <th>phases</th>\n",
       "      <th>description</th>\n",
       "      <th>inclusion_criteria</th>\n",
       "      <th>exclusion_criteria</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>disease</th>\n",
       "      <th>outcome_measures</th>\n",
       "      <th>outcome_timeframes</th>\n",
       "      <th>durationMonths</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03202394</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>This is a randomized, double blind, placebo co...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n1. Has provided (or rel...</td>\n",
       "      <td>:\\n\\n1. Age \\&lt; 18 years or \\&gt;75 years old\\n2. ...</td>\n",
       "      <td>['DRUG', 'DRUG']</td>\n",
       "      <td>['BIO-11006', 'Placebo']</td>\n",
       "      <td>['Respiratory Distress Syndrome, Adult']</td>\n",
       "      <td>['Incidence of treatment-emergent adverse even...</td>\n",
       "      <td>['28 days']</td>\n",
       "      <td>32.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02138214</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>PRIMARY OBJECTIVES:\\n\\nI. To determine the rat...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Pre-operative diagnos...</td>\n",
       "      <td>:\\n\\n* Largest papillary thyroid carcinoma \\&lt; ...</td>\n",
       "      <td>['PROCEDURE', 'PROCEDURE', 'OTHER']</td>\n",
       "      <td>['Thyroidectomy', 'entral lymph node dissectio...</td>\n",
       "      <td>['Stage I Papillary Thyroid Cancer', 'Stage II...</td>\n",
       "      <td>['Percentage of Participants With Transient Hy...</td>\n",
       "      <td>['Post-operative day 1', 'At day 12', '2 weeks...</td>\n",
       "      <td>65.733333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00976274</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>The details of study objective are followed by...</td>\n",
       "      <td>Inclusion Criteria:(three or more of following...</td>\n",
       "      <td>: (any one of following factors)\\n\\n* uncontro...</td>\n",
       "      <td>['DIETARY_SUPPLEMENT', 'DIETARY_SUPPLEMENT']</td>\n",
       "      <td>['Korean red ginseng', 'starch']</td>\n",
       "      <td>['Metabolic Syndrome']</td>\n",
       "      <td>['Change in the Pre- and Post-treatment Systol...</td>\n",
       "      <td>['baseline and 12 weeks']</td>\n",
       "      <td>17.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05529719</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>Objective: This study evaluates the effect of ...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* 18 to 30 years of age...</td>\n",
       "      <td>:\\n\\n* Volunteers who did not meet the inclusi...</td>\n",
       "      <td>['OTHER']</td>\n",
       "      <td>['Clinical Pilates Exercises']</td>\n",
       "      <td>['Low Back Pain']</td>\n",
       "      <td>['Prim Outcome - Oswestry Dysability Index']</td>\n",
       "      <td>['12 weeks']</td>\n",
       "      <td>25.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02323191</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>This Phase 1, open-label, multicenter, global ...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Eastern Cooperative O...</td>\n",
       "      <td>\\n* Measurable disease at baseline as per RECI...</td>\n",
       "      <td>['DRUG', 'DRUG']</td>\n",
       "      <td>['Atezolizumab', 'Emactuzumab']</td>\n",
       "      <td>['Solid Cancers']</td>\n",
       "      <td>['Percentage of Participants With Dose Limitin...</td>\n",
       "      <td>['21 days', '21 days', 'Baseline up to 3 years']</td>\n",
       "      <td>68.033333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184620</th>\n",
       "      <td>NCT05883852</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['PHASE3']</td>\n",
       "      <td>The objective of this study is to conduct a ra...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Women aged 18-70；\\n* ...</td>\n",
       "      <td>:\\n\\n* Bilateral breast cancer or carcinoma in...</td>\n",
       "      <td>['DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG']</td>\n",
       "      <td>['Docetaxel', 'carboplatin', 'Trastuzumab', 'P...</td>\n",
       "      <td>['HER2 Positive Early Breast Cancer']</td>\n",
       "      <td>['iDFS']</td>\n",
       "      <td>['5 years']</td>\n",
       "      <td>98.200000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184621</th>\n",
       "      <td>NCT02180724</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>Clinical studies have shown that targeting the...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n1. Men and women ≥18 ye...</td>\n",
       "      <td>:\\n\\n1. Prior malignancy, except for adequatel...</td>\n",
       "      <td>['DRUG', 'DRUG']</td>\n",
       "      <td>['Acalabrutinib (ACP-196)', 'Acalabrutinib (AC...</td>\n",
       "      <td>['Waldenström Macroglobulinemia (WM)']</td>\n",
       "      <td>['Overall Response Rate (ORR) of Acalabrutinib...</td>\n",
       "      <td>['Up to approximately 3.8 years. Data cut at w...</td>\n",
       "      <td>61.633333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184622</th>\n",
       "      <td>NCT00487305</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>* The dose of vaccine will depend upon how man...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Histologically confir...</td>\n",
       "      <td>:\\n\\n* Uncontrolled active infection or illnes...</td>\n",
       "      <td>['BIOLOGICAL']</td>\n",
       "      <td>['Lethally Irradiated Lymphoma cells with GM-C...</td>\n",
       "      <td>['Follicular Lymphoma']</td>\n",
       "      <td>['To determine the safety and toxicity of admi...</td>\n",
       "      <td>['2 years']</td>\n",
       "      <td>195.800000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184623</th>\n",
       "      <td>NCT05786924</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>BDTX-4933-101 is a first-in-human, open-label,...</td>\n",
       "      <td>Key Inclusion Criteria:\\n\\n1. Disease criteria...</td>\n",
       "      <td>:\\n\\n1. Cancer that has a known MEK1/2 mutatio...</td>\n",
       "      <td>['DRUG']</td>\n",
       "      <td>['BDTX-4933']</td>\n",
       "      <td>['Non-small Cell Lung Cancer', 'Histiocytic Ne...</td>\n",
       "      <td>['Dose Escalation: Incidence of dose-limiting ...</td>\n",
       "      <td>['The first 28-day cycle (Cycle 1)', 'Day 1 of...</td>\n",
       "      <td>38.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184624</th>\n",
       "      <td>NCT03644641</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>Perioperative increase in intraocular pressure...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Glasgow Coma scale 15...</td>\n",
       "      <td>:\\n\\n* postoperative artificial ventilation\\n*...</td>\n",
       "      <td>['PROCEDURE', 'PROCEDURE']</td>\n",
       "      <td>['Desflurane Group', 'Propofol Group']</td>\n",
       "      <td>['Vision; Disorder, Loss']</td>\n",
       "      <td>['Visual injury']</td>\n",
       "      <td>['48 hours']</td>\n",
       "      <td>36.600000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>184625 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              nctId                 status      phases  \\\n",
       "0       NCT03202394              COMPLETED  ['PHASE2']   \n",
       "1       NCT02138214              COMPLETED  ['PHASE2']   \n",
       "2       NCT00976274              COMPLETED      ['NA']   \n",
       "3       NCT05529719              COMPLETED      ['NA']   \n",
       "4       NCT02323191              COMPLETED  ['PHASE1']   \n",
       "...             ...                    ...         ...   \n",
       "184620  NCT05883852             RECRUITING  ['PHASE3']   \n",
       "184621  NCT02180724  ACTIVE_NOT_RECRUITING  ['PHASE2']   \n",
       "184622  NCT00487305  ACTIVE_NOT_RECRUITING  ['PHASE1']   \n",
       "184623  NCT05786924             RECRUITING  ['PHASE1']   \n",
       "184624  NCT03644641     NOT_YET_RECRUITING      ['NA']   \n",
       "\n",
       "                                              description  \\\n",
       "0       This is a randomized, double blind, placebo co...   \n",
       "1       PRIMARY OBJECTIVES:\\n\\nI. To determine the rat...   \n",
       "2       The details of study objective are followed by...   \n",
       "3       Objective: This study evaluates the effect of ...   \n",
       "4       This Phase 1, open-label, multicenter, global ...   \n",
       "...                                                   ...   \n",
       "184620  The objective of this study is to conduct a ra...   \n",
       "184621  Clinical studies have shown that targeting the...   \n",
       "184622  * The dose of vaccine will depend upon how man...   \n",
       "184623  BDTX-4933-101 is a first-in-human, open-label,...   \n",
       "184624  Perioperative increase in intraocular pressure...   \n",
       "\n",
       "                                       inclusion_criteria  \\\n",
       "0       Inclusion Criteria:\\n\\n1. Has provided (or rel...   \n",
       "1       Inclusion Criteria:\\n\\n* Pre-operative diagnos...   \n",
       "2       Inclusion Criteria:(three or more of following...   \n",
       "3       Inclusion Criteria:\\n\\n* 18 to 30 years of age...   \n",
       "4       Inclusion Criteria:\\n\\n* Eastern Cooperative O...   \n",
       "...                                                   ...   \n",
       "184620  Inclusion Criteria:\\n\\n* Women aged 18-70；\\n* ...   \n",
       "184621  Inclusion Criteria:\\n\\n1. Men and women ≥18 ye...   \n",
       "184622  Inclusion Criteria:\\n\\n* Histologically confir...   \n",
       "184623  Key Inclusion Criteria:\\n\\n1. Disease criteria...   \n",
       "184624  Inclusion Criteria:\\n\\n* Glasgow Coma scale 15...   \n",
       "\n",
       "                                       exclusion_criteria  \\\n",
       "0       :\\n\\n1. Age \\< 18 years or \\>75 years old\\n2. ...   \n",
       "1       :\\n\\n* Largest papillary thyroid carcinoma \\< ...   \n",
       "2       : (any one of following factors)\\n\\n* uncontro...   \n",
       "3       :\\n\\n* Volunteers who did not meet the inclusi...   \n",
       "4       \\n* Measurable disease at baseline as per RECI...   \n",
       "...                                                   ...   \n",
       "184620  :\\n\\n* Bilateral breast cancer or carcinoma in...   \n",
       "184621  :\\n\\n1. Prior malignancy, except for adequatel...   \n",
       "184622  :\\n\\n* Uncontrolled active infection or illnes...   \n",
       "184623  :\\n\\n1. Cancer that has a known MEK1/2 mutatio...   \n",
       "184624  :\\n\\n* postoperative artificial ventilation\\n*...   \n",
       "\n",
       "                                       intervention_type  \\\n",
       "0                                       ['DRUG', 'DRUG']   \n",
       "1                    ['PROCEDURE', 'PROCEDURE', 'OTHER']   \n",
       "2           ['DIETARY_SUPPLEMENT', 'DIETARY_SUPPLEMENT']   \n",
       "3                                              ['OTHER']   \n",
       "4                                       ['DRUG', 'DRUG']   \n",
       "...                                                  ...   \n",
       "184620  ['DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG']   \n",
       "184621                                  ['DRUG', 'DRUG']   \n",
       "184622                                    ['BIOLOGICAL']   \n",
       "184623                                          ['DRUG']   \n",
       "184624                        ['PROCEDURE', 'PROCEDURE']   \n",
       "\n",
       "                                        intervention_name  \\\n",
       "0                                ['BIO-11006', 'Placebo']   \n",
       "1       ['Thyroidectomy', 'entral lymph node dissectio...   \n",
       "2                        ['Korean red ginseng', 'starch']   \n",
       "3                          ['Clinical Pilates Exercises']   \n",
       "4                         ['Atezolizumab', 'Emactuzumab']   \n",
       "...                                                   ...   \n",
       "184620  ['Docetaxel', 'carboplatin', 'Trastuzumab', 'P...   \n",
       "184621  ['Acalabrutinib (ACP-196)', 'Acalabrutinib (AC...   \n",
       "184622  ['Lethally Irradiated Lymphoma cells with GM-C...   \n",
       "184623                                      ['BDTX-4933']   \n",
       "184624             ['Desflurane Group', 'Propofol Group']   \n",
       "\n",
       "                                                  disease  \\\n",
       "0                ['Respiratory Distress Syndrome, Adult']   \n",
       "1       ['Stage I Papillary Thyroid Cancer', 'Stage II...   \n",
       "2                                  ['Metabolic Syndrome']   \n",
       "3                                       ['Low Back Pain']   \n",
       "4                                       ['Solid Cancers']   \n",
       "...                                                   ...   \n",
       "184620              ['HER2 Positive Early Breast Cancer']   \n",
       "184621             ['Waldenström Macroglobulinemia (WM)']   \n",
       "184622                            ['Follicular Lymphoma']   \n",
       "184623  ['Non-small Cell Lung Cancer', 'Histiocytic Ne...   \n",
       "184624                         ['Vision; Disorder, Loss']   \n",
       "\n",
       "                                         outcome_measures  \\\n",
       "0       ['Incidence of treatment-emergent adverse even...   \n",
       "1       ['Percentage of Participants With Transient Hy...   \n",
       "2       ['Change in the Pre- and Post-treatment Systol...   \n",
       "3            ['Prim Outcome - Oswestry Dysability Index']   \n",
       "4       ['Percentage of Participants With Dose Limitin...   \n",
       "...                                                   ...   \n",
       "184620                                           ['iDFS']   \n",
       "184621  ['Overall Response Rate (ORR) of Acalabrutinib...   \n",
       "184622  ['To determine the safety and toxicity of admi...   \n",
       "184623  ['Dose Escalation: Incidence of dose-limiting ...   \n",
       "184624                                  ['Visual injury']   \n",
       "\n",
       "                                       outcome_timeframes  durationMonths  \n",
       "0                                             ['28 days']       32.266667  \n",
       "1       ['Post-operative day 1', 'At day 12', '2 weeks...       65.733333  \n",
       "2                               ['baseline and 12 weeks']       17.266667  \n",
       "3                                            ['12 weeks']       25.266667  \n",
       "4        ['21 days', '21 days', 'Baseline up to 3 years']       68.033333  \n",
       "...                                                   ...             ...  \n",
       "184620                                        ['5 years']       98.200000  \n",
       "184621  ['Up to approximately 3.8 years. Data cut at w...       61.633333  \n",
       "184622                                        ['2 years']      195.800000  \n",
       "184623  ['The first 28-day cycle (Cycle 1)', 'Day 1 of...       38.000000  \n",
       "184624                                       ['48 hours']       36.600000  \n",
       "\n",
       "[184625 rows x 12 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# import Dashboard DataFrame\n",
    "if os.path.isfile(\"./study_info_df.csv\"):\n",
    "    pass\n",
    "else:\n",
    "    # Should only take ~30 seconds\n",
    "    url = \"https://drive.google.com/file/d/1sSYhHvWkYVRFoB1ulEblmTwo9iSibYpG/view?usp=drive_link\"\n",
    "\n",
    "    output = \"study_info_df.csv\"\n",
    "\n",
    "    gdown.download(url, output, fuzzy=True)\n",
    "\n",
    "study_info_df = pd.read_csv(\"./study_info_df.csv\")\n",
    "study_info_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Test\n",
    "# with open(\"../_test/X_test.pkl\", \"rb\") as file:\n",
    "#     X_test = pickle.load(file)\n",
    "\n",
    "# with open(\"../_test/y_test.pkl\", \"rb\") as file:\n",
    "#     y_test = pickle.load(file)\n",
    "\n",
    "# Incomplete\n",
    "with open(\"./X_incompleted.pkl\", \"rb\") as file:\n",
    "    X_incompleted = pickle.load(file)\n",
    "\n",
    "with open(\"./y_incompleted.pkl\", \"rb\") as file:\n",
    "    y_incompleted = pickle.load(file)\n",
    "\n",
    "# PCA versions\n",
    "# with open(\"../_test/X_train_pca.pkl\", \"rb\") as file:\n",
    "#     X_train_pca = pickle.load(file)\n",
    "\n",
    "with open(\"./X_incompleted_pca.pkl\", \"rb\") as file:\n",
    "    X_incompleted_pca = pickle.load(file)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Linear Regression"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([19.69473811, 19.36546213,  5.28051592, ..., 71.65103307,\n",
       "       54.29086775, 26.15483794])"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load in pretrained model and get predicted values\n",
    "# lr = joblib.load(\"../_test/model_lr.sav\")\n",
    "lr = joblib.load(\"./model_lr.sav\")\n",
    "y_pred_lr = lr.predict(X_incompleted)\n",
    "y_pred_lr\n",
    "# print(lr.score)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Random Forest"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([40.26951708, 15.44139709, 24.77514241, ..., 63.95204551,\n",
       "       52.45273405, 21.9216853 ])"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load in pretrained model and get predicted values\n",
    "# rf = joblib.load(\"../_test/model_rf.sav\")\n",
    "rf = joblib.load(\"./model_rf.sav\")\n",
    "y_pred_rf = rf.predict(X_incompleted_pca)\n",
    "y_pred_rf"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# XGBoost"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([41.311485, 16.102915, 22.86373 , ..., 69.25941 , 54.54035 ,\n",
       "       15.755807], dtype=float32)"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load in pretrained model and get predicted values\n",
    "# with open(\"../_test/model_xgb.sav\", \"rb\") as f:\n",
    "with open(\"./model_xgb.sav\", \"rb\") as f:\n",
    "    xg = pickle.load(f)\n",
    "\n",
    "y_pred_xgb = xg.predict(X_incompleted_pca)\n",
    "y_pred_xgb"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# FFNN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1m1612/1612\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m2s\u001b[0m 701us/step\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "array([[25.756372],\n",
       "       [13.539691],\n",
       "       [17.498016],\n",
       "       ...,\n",
       "       [57.744637],\n",
       "       [50.911907],\n",
       "       [26.661886]], dtype=float32)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load in pretrained model and get predicted values\n",
    "ffnn = load_model(\n",
    "    # \"../_test/model_ffnn.keras\", custom_objects=None, compile=True, safe_mode=True\n",
    "    \"./model_ffnn.keras\", custom_objects=None, compile=True, safe_mode=True\n",
    ")\n",
    "y_pred_ffnn = ffnn.predict(X_incompleted)\n",
    "y_pred_ffnn"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# CNN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1m1612/1612\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m24s\u001b[0m 15ms/step\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "array([[27.747698],\n",
       "       [13.165504],\n",
       "       [19.505201],\n",
       "       ...,\n",
       "       [61.07513 ],\n",
       "       [50.798626],\n",
       "       [22.996641]], dtype=float32)"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load in pretrained model and get predicted values\n",
    "cnn = load_model(\n",
    "    # \"../_test/model_cnn.keras\", custom_objects=None, compile=True, safe_mode=True\n",
    "     \"./model_cnn.keras\", custom_objects=None, compile=True, safe_mode=True\n",
    ")\n",
    "y_pred_cnn = cnn.predict(X_incompleted)\n",
    "y_pred_cnn"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Combine All Model Predictions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Linear Regression 834.8014383046133\n",
      "Random Forest 885.2747287659091\n",
      "XGBoost 821.7040187854658\n",
      "FFNN 821.5441732255206\n",
      "CNN 823.3580548682285\n"
     ]
    }
   ],
   "source": [
    "# Compare the mse to see which predictions to use\n",
    "preds = [y_pred_lr, y_pred_rf, y_pred_xgb, y_pred_ffnn, y_pred_cnn]\n",
    "models = [\"Linear Regression\", \"Random Forest\", \"XGBoost\", \"FFNN\", \"CNN\"]\n",
    "\n",
    "for i, p in enumerate(preds):\n",
    "    try:\n",
    "        mse = mean_squared_error(y_incompleted, p)\n",
    "    except:\n",
    "        mse = mean_squared_error(y_test, p)\n",
    "\n",
    "    print(models[i], mse)\n",
    "    # Around 29 error"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Add best model predictions to Dashboard DataFrame"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nctId</th>\n",
       "      <th>status</th>\n",
       "      <th>phases</th>\n",
       "      <th>description</th>\n",
       "      <th>inclusion_criteria</th>\n",
       "      <th>exclusion_criteria</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>disease</th>\n",
       "      <th>outcome_measures</th>\n",
       "      <th>outcome_timeframes</th>\n",
       "      <th>durationMonths</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03202394</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>This is a randomized, double blind, placebo co...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n1. Has provided (or rel...</td>\n",
       "      <td>:\\n\\n1. Age \\&lt; 18 years or \\&gt;75 years old\\n2. ...</td>\n",
       "      <td>['DRUG', 'DRUG']</td>\n",
       "      <td>['BIO-11006', 'Placebo']</td>\n",
       "      <td>['Respiratory Distress Syndrome, Adult']</td>\n",
       "      <td>['Incidence of treatment-emergent adverse even...</td>\n",
       "      <td>['28 days']</td>\n",
       "      <td>32.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02138214</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>PRIMARY OBJECTIVES:\\n\\nI. To determine the rat...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Pre-operative diagnos...</td>\n",
       "      <td>:\\n\\n* Largest papillary thyroid carcinoma \\&lt; ...</td>\n",
       "      <td>['PROCEDURE', 'PROCEDURE', 'OTHER']</td>\n",
       "      <td>['Thyroidectomy', 'entral lymph node dissectio...</td>\n",
       "      <td>['Stage I Papillary Thyroid Cancer', 'Stage II...</td>\n",
       "      <td>['Percentage of Participants With Transient Hy...</td>\n",
       "      <td>['Post-operative day 1', 'At day 12', '2 weeks...</td>\n",
       "      <td>65.733333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00976274</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>The details of study objective are followed by...</td>\n",
       "      <td>Inclusion Criteria:(three or more of following...</td>\n",
       "      <td>: (any one of following factors)\\n\\n* uncontro...</td>\n",
       "      <td>['DIETARY_SUPPLEMENT', 'DIETARY_SUPPLEMENT']</td>\n",
       "      <td>['Korean red ginseng', 'starch']</td>\n",
       "      <td>['Metabolic Syndrome']</td>\n",
       "      <td>['Change in the Pre- and Post-treatment Systol...</td>\n",
       "      <td>['baseline and 12 weeks']</td>\n",
       "      <td>17.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05529719</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>Objective: This study evaluates the effect of ...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* 18 to 30 years of age...</td>\n",
       "      <td>:\\n\\n* Volunteers who did not meet the inclusi...</td>\n",
       "      <td>['OTHER']</td>\n",
       "      <td>['Clinical Pilates Exercises']</td>\n",
       "      <td>['Low Back Pain']</td>\n",
       "      <td>['Prim Outcome - Oswestry Dysability Index']</td>\n",
       "      <td>['12 weeks']</td>\n",
       "      <td>25.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02323191</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>This Phase 1, open-label, multicenter, global ...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Eastern Cooperative O...</td>\n",
       "      <td>\\n* Measurable disease at baseline as per RECI...</td>\n",
       "      <td>['DRUG', 'DRUG']</td>\n",
       "      <td>['Atezolizumab', 'Emactuzumab']</td>\n",
       "      <td>['Solid Cancers']</td>\n",
       "      <td>['Percentage of Participants With Dose Limitin...</td>\n",
       "      <td>['21 days', '21 days', 'Baseline up to 3 years']</td>\n",
       "      <td>68.033333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184620</th>\n",
       "      <td>NCT05883852</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['PHASE3']</td>\n",
       "      <td>The objective of this study is to conduct a ra...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Women aged 18-70；\\n* ...</td>\n",
       "      <td>:\\n\\n* Bilateral breast cancer or carcinoma in...</td>\n",
       "      <td>['DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG']</td>\n",
       "      <td>['Docetaxel', 'carboplatin', 'Trastuzumab', 'P...</td>\n",
       "      <td>['HER2 Positive Early Breast Cancer']</td>\n",
       "      <td>['iDFS']</td>\n",
       "      <td>['5 years']</td>\n",
       "      <td>98.200000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184621</th>\n",
       "      <td>NCT02180724</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>['PHASE2']</td>\n",
       "      <td>Clinical studies have shown that targeting the...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n1. Men and women ≥18 ye...</td>\n",
       "      <td>:\\n\\n1. Prior malignancy, except for adequatel...</td>\n",
       "      <td>['DRUG', 'DRUG']</td>\n",
       "      <td>['Acalabrutinib (ACP-196)', 'Acalabrutinib (AC...</td>\n",
       "      <td>['Waldenström Macroglobulinemia (WM)']</td>\n",
       "      <td>['Overall Response Rate (ORR) of Acalabrutinib...</td>\n",
       "      <td>['Up to approximately 3.8 years. Data cut at w...</td>\n",
       "      <td>61.633333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184622</th>\n",
       "      <td>NCT00487305</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>* The dose of vaccine will depend upon how man...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Histologically confir...</td>\n",
       "      <td>:\\n\\n* Uncontrolled active infection or illnes...</td>\n",
       "      <td>['BIOLOGICAL']</td>\n",
       "      <td>['Lethally Irradiated Lymphoma cells with GM-C...</td>\n",
       "      <td>['Follicular Lymphoma']</td>\n",
       "      <td>['To determine the safety and toxicity of admi...</td>\n",
       "      <td>['2 years']</td>\n",
       "      <td>195.800000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184623</th>\n",
       "      <td>NCT05786924</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>['PHASE1']</td>\n",
       "      <td>BDTX-4933-101 is a first-in-human, open-label,...</td>\n",
       "      <td>Key Inclusion Criteria:\\n\\n1. Disease criteria...</td>\n",
       "      <td>:\\n\\n1. Cancer that has a known MEK1/2 mutatio...</td>\n",
       "      <td>['DRUG']</td>\n",
       "      <td>['BDTX-4933']</td>\n",
       "      <td>['Non-small Cell Lung Cancer', 'Histiocytic Ne...</td>\n",
       "      <td>['Dose Escalation: Incidence of dose-limiting ...</td>\n",
       "      <td>['The first 28-day cycle (Cycle 1)', 'Day 1 of...</td>\n",
       "      <td>38.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184624</th>\n",
       "      <td>NCT03644641</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>['NA']</td>\n",
       "      <td>Perioperative increase in intraocular pressure...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n* Glasgow Coma scale 15...</td>\n",
       "      <td>:\\n\\n* postoperative artificial ventilation\\n*...</td>\n",
       "      <td>['PROCEDURE', 'PROCEDURE']</td>\n",
       "      <td>['Desflurane Group', 'Propofol Group']</td>\n",
       "      <td>['Vision; Disorder, Loss']</td>\n",
       "      <td>['Visual injury']</td>\n",
       "      <td>['48 hours']</td>\n",
       "      <td>36.600000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>184625 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              nctId                 status      phases  \\\n",
       "0       NCT03202394              COMPLETED  ['PHASE2']   \n",
       "1       NCT02138214              COMPLETED  ['PHASE2']   \n",
       "2       NCT00976274              COMPLETED      ['NA']   \n",
       "3       NCT05529719              COMPLETED      ['NA']   \n",
       "4       NCT02323191              COMPLETED  ['PHASE1']   \n",
       "...             ...                    ...         ...   \n",
       "184620  NCT05883852             RECRUITING  ['PHASE3']   \n",
       "184621  NCT02180724  ACTIVE_NOT_RECRUITING  ['PHASE2']   \n",
       "184622  NCT00487305  ACTIVE_NOT_RECRUITING  ['PHASE1']   \n",
       "184623  NCT05786924             RECRUITING  ['PHASE1']   \n",
       "184624  NCT03644641     NOT_YET_RECRUITING      ['NA']   \n",
       "\n",
       "                                              description  \\\n",
       "0       This is a randomized, double blind, placebo co...   \n",
       "1       PRIMARY OBJECTIVES:\\n\\nI. To determine the rat...   \n",
       "2       The details of study objective are followed by...   \n",
       "3       Objective: This study evaluates the effect of ...   \n",
       "4       This Phase 1, open-label, multicenter, global ...   \n",
       "...                                                   ...   \n",
       "184620  The objective of this study is to conduct a ra...   \n",
       "184621  Clinical studies have shown that targeting the...   \n",
       "184622  * The dose of vaccine will depend upon how man...   \n",
       "184623  BDTX-4933-101 is a first-in-human, open-label,...   \n",
       "184624  Perioperative increase in intraocular pressure...   \n",
       "\n",
       "                                       inclusion_criteria  \\\n",
       "0       Inclusion Criteria:\\n\\n1. Has provided (or rel...   \n",
       "1       Inclusion Criteria:\\n\\n* Pre-operative diagnos...   \n",
       "2       Inclusion Criteria:(three or more of following...   \n",
       "3       Inclusion Criteria:\\n\\n* 18 to 30 years of age...   \n",
       "4       Inclusion Criteria:\\n\\n* Eastern Cooperative O...   \n",
       "...                                                   ...   \n",
       "184620  Inclusion Criteria:\\n\\n* Women aged 18-70；\\n* ...   \n",
       "184621  Inclusion Criteria:\\n\\n1. Men and women ≥18 ye...   \n",
       "184622  Inclusion Criteria:\\n\\n* Histologically confir...   \n",
       "184623  Key Inclusion Criteria:\\n\\n1. Disease criteria...   \n",
       "184624  Inclusion Criteria:\\n\\n* Glasgow Coma scale 15...   \n",
       "\n",
       "                                       exclusion_criteria  \\\n",
       "0       :\\n\\n1. Age \\< 18 years or \\>75 years old\\n2. ...   \n",
       "1       :\\n\\n* Largest papillary thyroid carcinoma \\< ...   \n",
       "2       : (any one of following factors)\\n\\n* uncontro...   \n",
       "3       :\\n\\n* Volunteers who did not meet the inclusi...   \n",
       "4       \\n* Measurable disease at baseline as per RECI...   \n",
       "...                                                   ...   \n",
       "184620  :\\n\\n* Bilateral breast cancer or carcinoma in...   \n",
       "184621  :\\n\\n1. Prior malignancy, except for adequatel...   \n",
       "184622  :\\n\\n* Uncontrolled active infection or illnes...   \n",
       "184623  :\\n\\n1. Cancer that has a known MEK1/2 mutatio...   \n",
       "184624  :\\n\\n* postoperative artificial ventilation\\n*...   \n",
       "\n",
       "                                       intervention_type  \\\n",
       "0                                       ['DRUG', 'DRUG']   \n",
       "1                    ['PROCEDURE', 'PROCEDURE', 'OTHER']   \n",
       "2           ['DIETARY_SUPPLEMENT', 'DIETARY_SUPPLEMENT']   \n",
       "3                                              ['OTHER']   \n",
       "4                                       ['DRUG', 'DRUG']   \n",
       "...                                                  ...   \n",
       "184620  ['DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG', 'DRUG']   \n",
       "184621                                  ['DRUG', 'DRUG']   \n",
       "184622                                    ['BIOLOGICAL']   \n",
       "184623                                          ['DRUG']   \n",
       "184624                        ['PROCEDURE', 'PROCEDURE']   \n",
       "\n",
       "                                        intervention_name  \\\n",
       "0                                ['BIO-11006', 'Placebo']   \n",
       "1       ['Thyroidectomy', 'entral lymph node dissectio...   \n",
       "2                        ['Korean red ginseng', 'starch']   \n",
       "3                          ['Clinical Pilates Exercises']   \n",
       "4                         ['Atezolizumab', 'Emactuzumab']   \n",
       "...                                                   ...   \n",
       "184620  ['Docetaxel', 'carboplatin', 'Trastuzumab', 'P...   \n",
       "184621  ['Acalabrutinib (ACP-196)', 'Acalabrutinib (AC...   \n",
       "184622  ['Lethally Irradiated Lymphoma cells with GM-C...   \n",
       "184623                                      ['BDTX-4933']   \n",
       "184624             ['Desflurane Group', 'Propofol Group']   \n",
       "\n",
       "                                                  disease  \\\n",
       "0                ['Respiratory Distress Syndrome, Adult']   \n",
       "1       ['Stage I Papillary Thyroid Cancer', 'Stage II...   \n",
       "2                                  ['Metabolic Syndrome']   \n",
       "3                                       ['Low Back Pain']   \n",
       "4                                       ['Solid Cancers']   \n",
       "...                                                   ...   \n",
       "184620              ['HER2 Positive Early Breast Cancer']   \n",
       "184621             ['Waldenström Macroglobulinemia (WM)']   \n",
       "184622                            ['Follicular Lymphoma']   \n",
       "184623  ['Non-small Cell Lung Cancer', 'Histiocytic Ne...   \n",
       "184624                         ['Vision; Disorder, Loss']   \n",
       "\n",
       "                                         outcome_measures  \\\n",
       "0       ['Incidence of treatment-emergent adverse even...   \n",
       "1       ['Percentage of Participants With Transient Hy...   \n",
       "2       ['Change in the Pre- and Post-treatment Systol...   \n",
       "3            ['Prim Outcome - Oswestry Dysability Index']   \n",
       "4       ['Percentage of Participants With Dose Limitin...   \n",
       "...                                                   ...   \n",
       "184620                                           ['iDFS']   \n",
       "184621  ['Overall Response Rate (ORR) of Acalabrutinib...   \n",
       "184622  ['To determine the safety and toxicity of admi...   \n",
       "184623  ['Dose Escalation: Incidence of dose-limiting ...   \n",
       "184624                                  ['Visual injury']   \n",
       "\n",
       "                                       outcome_timeframes  durationMonths  \n",
       "0                                             ['28 days']       32.266667  \n",
       "1       ['Post-operative day 1', 'At day 12', '2 weeks...       65.733333  \n",
       "2                               ['baseline and 12 weeks']       17.266667  \n",
       "3                                            ['12 weeks']       25.266667  \n",
       "4        ['21 days', '21 days', 'Baseline up to 3 years']       68.033333  \n",
       "...                                                   ...             ...  \n",
       "184620                                        ['5 years']       98.200000  \n",
       "184621  ['Up to approximately 3.8 years. Data cut at w...       61.633333  \n",
       "184622                                        ['2 years']      195.800000  \n",
       "184623  ['The first 28-day cycle (Cycle 1)', 'Day 1 of...       38.000000  \n",
       "184624                                       ['48 hours']       36.600000  \n",
       "\n",
       "[184625 rows x 12 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# DELETE ONCE WHOLE NOTEBOOK WORKS\n",
    "# study_info_df = pd.read_csv(\"./study_info_df.csv\")\n",
    "\n",
    "study_info_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nctId</th>\n",
       "      <th>status</th>\n",
       "      <th>studyType</th>\n",
       "      <th>primaryPurpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT05499390</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT05441683</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05613686</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05497843</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT06157541</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52164</th>\n",
       "      <td>NCT05883852</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52165</th>\n",
       "      <td>NCT02180724</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52166</th>\n",
       "      <td>NCT00487305</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52167</th>\n",
       "      <td>NCT05786924</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52168</th>\n",
       "      <td>NCT03644641</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TREATMENT</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>52169 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             nctId                 status       studyType primaryPurpose\n",
       "0      NCT05499390  ACTIVE_NOT_RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "1      NCT05441683             RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "2      NCT05613686             RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "3      NCT05497843             RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "4      NCT06157541             RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "...            ...                    ...             ...            ...\n",
       "52164  NCT05883852             RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "52165  NCT02180724  ACTIVE_NOT_RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "52166  NCT00487305  ACTIVE_NOT_RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "52167  NCT05786924             RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "52168  NCT03644641     NOT_YET_RECRUITING  INTERVENTIONAL      TREATMENT\n",
       "\n",
       "[52169 rows x 4 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get incompleted NCTIDs to use to merge with Dashboard DataFrame\n",
    "incompleted_ids = pd.read_csv(\"../results/incompleted_ids.csv\")\n",
    "incompleted_ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nctId</th>\n",
       "      <th>predicted_durationMonths</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT05499390</td>\n",
       "      <td>25.756372</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT05441683</td>\n",
       "      <td>13.539691</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05613686</td>\n",
       "      <td>17.498016</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05497843</td>\n",
       "      <td>38.387852</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT06157541</td>\n",
       "      <td>42.911945</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51548</th>\n",
       "      <td>NCT05883852</td>\n",
       "      <td>48.514359</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51549</th>\n",
       "      <td>NCT02180724</td>\n",
       "      <td>25.597454</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51550</th>\n",
       "      <td>NCT00487305</td>\n",
       "      <td>57.744637</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51551</th>\n",
       "      <td>NCT05786924</td>\n",
       "      <td>50.911907</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51552</th>\n",
       "      <td>NCT03644641</td>\n",
       "      <td>26.661886</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>51553 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             nctId  predicted_durationMonths\n",
       "0      NCT05499390                 25.756372\n",
       "1      NCT05441683                 13.539691\n",
       "2      NCT05613686                 17.498016\n",
       "3      NCT05497843                 38.387852\n",
       "4      NCT06157541                 42.911945\n",
       "...            ...                       ...\n",
       "51548  NCT05883852                 48.514359\n",
       "51549  NCT02180724                 25.597454\n",
       "51550  NCT00487305                 57.744637\n",
       "51551  NCT05786924                 50.911907\n",
       "51552  NCT03644641                 26.661886\n",
       "\n",
       "[51553 rows x 2 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Add predicted durations onto df, removing ones that were unable to be embedded due to NaNs\n",
    "incompleted_preds_df = study_info_df[\n",
    "    study_info_df.nctId.isin(list(incompleted_ids.nctId))\n",
    "].dropna(\n",
    "    subset=[\n",
    "        \"intervention_name\",\n",
    "        \"exclusion_criteria\",\n",
    "        \"outcome_measures\",\n",
    "        \"outcome_timeframes\",\n",
    "    ]\n",
    ")\n",
    "incompleted_preds_df[\"predicted_durationMonths\"] = y_pred_ffnn\n",
    "incompleted_preds_df = incompleted_preds_df[\n",
    "    [\"nctId\", \"predicted_durationMonths\"]\n",
    "].reset_index(drop=True)\n",
    "incompleted_preds_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save for use with TrialDuraPredict_Dashboard Jupyter Notebook file\n",
    "incompleted_preds_df.to_csv(\"../results/incompleted_preds_df.csv\", index=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Scoring Predictions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "MSE:\n",
      "Linear Regression:  834.8014383046133\n",
      "Random Forest Regresion:  885.2747287659091\n",
      "XGBoost:  821.7040187854658\n",
      "FFNN:  821.5441732255206\n",
      "CNN:  823.3580548682285\n",
      "\n",
      "R²\n",
      "Linear Regression:  0.24654237929312162\n",
      "Random Forest Regresion:  0.2009872525345373\n",
      "XGBoost:  0.25836357424498724\n",
      "FFNN:  0.25850784430700524\n",
      "CNN:  0.25687070895475406\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "from sklearn.metrics import mean_squared_error, r2_score\n",
    "\n",
    "#y_pred_xgb, y_pred_ffnn, y_pred_cnn\n",
    "# Calculate Mean Squared Error (MSE) and R-squared (R²)\n",
    "mse_lr = mean_squared_error(y_incompleted, y_pred_lr)\n",
    "mse_rf = mean_squared_error(y_incompleted, y_pred_rf)\n",
    "mse_xgb = mean_squared_error(y_incompleted, y_pred_xgb)\n",
    "mse_ffnn = mean_squared_error(y_incompleted, y_pred_ffnn)\n",
    "mse_cnn = mean_squared_error(y_incompleted, y_pred_cnn)\n",
    "\n",
    "r2_lr = r2_score(y_incompleted, y_pred_lr)\n",
    "r2_rf = r2_score(y_incompleted, y_pred_rf)\n",
    "r2_xgb = r2_score(y_incompleted, y_pred_xgb)\n",
    "r2_ffnn = r2_score(y_incompleted, y_pred_ffnn)\n",
    "r2_cnn = r2_score(y_incompleted, y_pred_cnn)\n",
    "\n",
    "print(\"MSE:\")\n",
    "print(\"Linear Regression: \", mse_lr)\n",
    "print(\"Random Forest Regresion: \", mse_rf)\n",
    "print(\"XGBoost: \", mse_xgb)\n",
    "print(\"FFNN: \", mse_ffnn)\n",
    "print(\"CNN: \", mse_cnn)\n",
    "\n",
    "print(\"\\nR²\")\n",
    "print(\"Linear Regression: \", r2_lr)\n",
    "print(\"Random Forest Regresion: \", r2_rf)\n",
    "print(\"XGBoost: \", r2_xgb)\n",
    "print(\"FFNN: \", r2_ffnn)\n",
    "print(\"CNN: \", r2_cnn)\n",
    "\n",
    "# Plot the results\n",
    "plt.scatter(y_incompleted, y_pred_lr, label='Linear Regression', color='r')\n",
    "plt.scatter(y_incompleted, y_pred_rf, label='Random Forest Regression', color='g')\n",
    "plt.scatter(y_incompleted, y_pred_xgb, label='XGBoost', color='b')\n",
    "plt.scatter(y_incompleted, y_pred_ffnn, label='FFNN', color='orange')\n",
    "plt.scatter(y_incompleted, y_pred_cnn, label='CNN', color='purple')\n",
    "plt.xlabel(\"Actual MPG\")\n",
    "plt.ylabel(\"Predicted MPG\")\n",
    "plt.legend()\n",
    "plt.title(\"Model Comparison\")\n",
    "plt.axis([400, 1200, -50, 150])\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The MSE measures the average squared difference between the actual MPG values and the MPG values predicted by the Linear Regression model. Therefore, the model with the lowest MSE would be a better fit for the data. In this case, that is the FNN model. \n",
    "<br>The R² value represents the proportion of the variance in the MPG values that can be explained by the models. The FNN R² value of 0.2585 means that the model explains 25.85% of the variance in the target variable. This is the highest of all of our R² values, which means that it is the best fit for our data."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
